MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026

MER Primary Care Conferences 2026 | Internal Medicine, Dermatology, Gastroenterology, Oncology, Colorectal Cancer Screening, Hepatitis, Skin Lesions & Cancer Prevention

The MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026 program provides a comprehensive, evidence-based educational update on common and complex conditions encountered in adult primary care medicine.

Organized by Medical Education Resources (MER), this three-day continuing medical education conference integrates important clinical developments across dermatology, gastroenterology, oncology, and general internal medicine.

Held October 2–4, 2026, at the Holiday Inn Estes Park near Rocky Mountain National Park, Colorado, the program emphasizes practical diagnostic approaches, current treatment recommendations, preventive medicine, clinical procedures, and appropriate specialty referral.

The MER Internal Medicine for Primary Care Dermatology Gastroenterology Oncology 2026 curriculum covers lower gastrointestinal bleeding, colorectal cancer screening and surveillance, celiac disease, chronic diarrhea, hepatitis B and C management, skin manifestations of systemic disease, acneiform eruptions, benign and malignant skin tumors, cancer prevention, evaluation of suspected malignancy, cancer survivorship, and oral anticoagulation.

Through 12 focused educational presentations, clinicians review important medical conditions that frequently overlap across primary care and specialty medicine.

The program is designed to help office-based healthcare professionals improve diagnostic accuracy, understand evolving clinical recommendations, recognize serious disease presentations, and select appropriate management strategies.

Course Details

• Course: MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026
• Official Program: Internal Medicine for Primary Care: Dermatology/Gastroenterology/Oncology
• Organizer: Medical Education Resources (MER)
• Dates: October 2–4, 2026
• Location: Rocky Mountain National Park Area, Colorado, USA
• Venue: Holiday Inn Estes Park
• Venue Address: 101 S. St. Vrain Avenue, Estes Park, Colorado 80517
• Official Conference Format: In-Person
• Duration: Three Days
• Primary Specialty: Internal Medicine / Primary Care
• Additional Focus: Dermatology, Gastroenterology, Hepatology, Oncology, Hematology and Preventive Medicine
• Language: English
• Published Educational Lectures: 12
• Official AMA CME: Up to 12 AMA PRA Category 1 Credits™
• ABIM MOC: Up to 12 Points
• AAFP Credit: Up to 12 Live AAFP Prescribed Credits
• ANCC Nursing Credit: Up to 12 Contact Hours
• ANCC Pharmacotherapeutic Credit: 5.5 Contact Hours
• IPCE: 12 Credits
• AAPA CME: Up to 12 Category 1 CME Credits

The credits described above apply to eligible participation in the original MER live conference and do not accompany separately purchased MedicalAmboss educational files.

Target Audience

The program is designed for office-based primary care practitioners and other healthcare professionals seeking practical updates in adult outpatient medicine.

The target audience includes:

• Internal Medicine Physicians
• General Internists
• Family Medicine Physicians
• Primary Care Physicians
• General Practitioners
• Gastroenterologists
• Hepatologists
• Dermatologists
• Medical Oncologists
• Hematologists
• Surgical Oncologists
• Preventive Medicine Physicians
• Hospitalists
• Physician Assistants
• Nurse Practitioners
• Registered Nurses
• Advanced Practice Providers
• Medical Residents
• Clinical Fellows
• Other Healthcare Professionals Involved in Primary Care

The program is especially relevant to clinicians responsible for evaluating gastrointestinal complaints, liver disease, skin lesions, cancer-related symptoms, and long-term survivorship needs.

Program Overview

Primary care physicians frequently encounter patients with symptoms that require knowledge spanning multiple medical specialties.

Abdominal bleeding, chronic diarrhea, abnormal liver tests, skin eruptions, suspicious lesions, cancer-related symptoms, and anticoagulant use can create significant diagnostic and therapeutic challenges.

The MER Primary Care Conferences Derm/Gastro/Onc 2026 program addresses these challenges through multidisciplinary educational sessions.

The curriculum covers:

• Lower Gastrointestinal Bleeding
• Occult Blood Testing
• Hematochezia
• Colorectal Cancer Screening
• Colorectal Cancer Surveillance
• Colonoscopy Recommendations
• Celiac Disease
• Chronic Diarrhea
• Malabsorption
• Hepatitis B
• Hepatitis C
• Chronic Liver Disease
• Skin Manifestations of Systemic Disease
• Acne
• Acneiform Eruptions
• Folliculitis
• Hidradenitis Suppurativa
• Rosacea
• Benign Skin Tumors
• Skin Biopsy Techniques
• Premalignant Skin Lesions
• Basal Cell Carcinoma
• Squamous Cell Carcinoma
• Melanoma
• Cancer Prevention
• Evaluation of Suspected Cancer
• Cancer Survivorship
• Cancer Recurrence Surveillance
• Direct Oral Anticoagulants
• Perioperative Anticoagulation Management
• Anticoagulant Reversal

The educational program emphasizes evidence-based diagnosis, current treatment recommendations, prevention, and clinical decision-making.

Learning Objectives

Upon completion of the original educational program, participants should be better able to:

1. List current treatment recommendations for the management of lower gastrointestinal bleeding.
2. Discuss guidelines for colonoscopic colorectal cancer screening and surveillance.
3. Recommend appropriate testing for the evaluation of celiac disease.
4. List current treatment recommendations for hepatitis B virus (HBV) and hepatitis C virus (HCV).
5. Identify cutaneous findings that may serve as clinical indicators of underlying internal diseases.
6. Describe a stepwise approach to the diagnosis and treatment of acne and acneiform eruptions.
7. Differentiate benign and malignant skin tumors and employ appropriate office-based dermatologic procedures.
8. Detect premalignant and malignant skin lesions.
9. Identify clinical practices shown to prevent cancer.
10. Discuss the diagnostic approach to patients with suspected malignancy.
11. Evaluate and manage important medical risks associated with cancer survivorship.
12. Manage patients receiving newer oral anticoagulant medications.

Official Program Topics

Day 1 – Friday, October 2, 2026

All times are local Mountain Time.

Session I – Gastroenterology

Management of Lower GI Bleeding – From Occult to Massive

7:30 AM – 8:30 AM

This presentation reviews the clinical evaluation and management of lower gastrointestinal bleeding, ranging from occult blood loss to major hematochezia.

Lower GI bleeding is an important clinical presentation that may require careful evaluation to determine the source, severity, and urgency of intervention.

Important considerations include:

• Lower Gastrointestinal Bleeding
• Occult GI Bleeding
• Hematochezia
• Clinical History
• Hemodynamic Assessment
• Diagnostic Evaluation
• Fecal Occult Blood Testing
• Interpretation of Stool Blood Tests
• Colonic Bleeding Sources
• Diagnostic and Therapeutic Strategies
• Risk Stratification
• Appropriate Referral
• Management of Severe Bleeding

The session emphasizes selecting appropriate diagnostic and management approaches according to clinical presentation and bleeding severity.

Colorectal Cancer Screening and Surveillance

8:30 AM – 9:30 AM

This session reviews current colorectal cancer screening recommendations for average-risk individuals and the role of surveillance following abnormal findings.

Important topics include:

• Colorectal Cancer Prevention
• Screening Eligibility
• Average-Risk Adults
• Colonoscopy
• Stool-Based Screening
• Screening Intervals
• Surveillance Colonoscopy
• Adenomatous Polyps
• Risk-Based Follow-Up
• Benefits and Limitations of Screening
• Patient Counseling
• Shared Decision-Making

The educational emphasis is on applying current colorectal cancer screening recommendations and determining appropriate follow-up.

Celiac Disease and Chronic Diarrhea

9:40 AM – 10:40 AM

This presentation examines the diagnostic evaluation of chronic diarrhea and malabsorption, with emphasis on celiac disease.

Although gluten-free diets have become increasingly common, not every patient following a gluten-free diet has confirmed celiac disease.

Important considerations include:

• Celiac Disease
• Chronic Diarrhea
• Malabsorption
• Gluten-Related Disorders
• Diagnostic Serology
• Tissue Transglutaminase Antibodies
• Total Immunoglobulin A
• Duodenal Biopsy
• Differential Diagnosis
• Diagnostic Challenges During Gluten Restriction
• Nutritional Deficiencies
• Appropriate Testing
• Gastroenterology Referral

The session addresses how clinicians should approach diagnostic testing when patients have already begun avoiding gluten.

Session II – Dermatology

Skin Manifestations of Systemic Disease

10:40 AM – 11:40 AM

Skin findings may reflect underlying systemic illnesses or complications of medical treatment.

This presentation reviews the importance of recognizing cutaneous signs that may provide diagnostic clues to internal disease.

Important topics include:

• Cutaneous Manifestations
• Systemic Disease
• Rheumatologic Disorders
• Endocrine Disorders
• Gastrointestinal Disease
• Inflammatory Conditions
• Medication-Related Skin Changes
• Dermatologic Examination
• Differential Diagnosis
• Recognition of Internal Disease
• Appropriate Investigations
• Specialist Referral

The session emphasizes integrating dermatological findings into broader medical assessment.

Acne and Acneiform Eruptions

11:40 AM – 12:40 PM

This presentation provides a clinical review of acne and related dermatologic conditions commonly encountered in primary care.

Important topics include:

• Acne Vulgaris
• Open Comedones
• Closed Comedones
• Inflammatory Acne
• Acne Severity Assessment
• Bacterial Folliculitis
• Drug-Induced Acne
• Hidradenitis Suppurativa
• Miliaria
• Perioral Dermatitis
• Pseudofolliculitis Barbae
• Rosacea
• Seborrheic Dermatitis
• Topical Treatment
• Systemic Treatment
• Treatment Selection
• Dermatology Referral

The session emphasizes classifying acne severity and applying appropriate stepwise treatment strategies.

12:40 PM – Day 1 Session Adjournment

Day 2 – Saturday, October 3, 2026

Session III – Dermatology

Benign Skin Tumors

7:30 AM – 8:30 AM

This session examines the diagnosis and treatment of common benign skin tumors.

Primary care physicians frequently evaluate pigmented lesions, skin growths, and other dermatologic findings that require differentiation from malignant conditions.

Important topics include:

• Benign Skin Tumors
• Melanocytic Nevi
• Seborrheic Keratoses
• Keloids
• Hemangiomas
• Other Benign Lesions
• Clinical Examination
• Diagnostic Assessment
• Skin Biopsy
• Histopathology
• Treatment Options
• Referral Indications

The session emphasizes appropriate clinical recognition and management of benign skin lesions.

Premalignant and Malignant Skin Tumors

8:30 AM – 9:30 AM

This presentation reviews recognition of premalignant and malignant skin tumors and the importance of early diagnosis.

Important topics include:

• Actinic Keratosis
• Bowen’s Disease
• Squamous Cell Carcinoma
• Basal Cell Carcinoma
• Melanoma
• Suspicious Skin Lesions
• Clinical Warning Signs
• Premalignant Skin Conditions
• Punch Biopsy
• Excisional Biopsy
• Histopathological Diagnosis
• Skin Cancer Risk Reduction
• Dermatology Referral
• Patient Education

The session emphasizes early identification of suspicious skin lesions and appropriate diagnostic procedures.

Session IV – Gastroenterology and Hepatology

Hepatitis B and C Management

9:40 AM – 10:40 AM

This presentation reviews important developments in the evaluation and management of viral hepatitis.

The session emphasizes hepatitis B screening, vaccination, treatment considerations, and clinical management of patients with chronic liver disease.

Important topics include:

• Hepatitis B Virus
• Hepatitis C Virus
• HBV Screening
• HCV Screening
• Hepatitis B Vaccination
• Chronic Viral Hepatitis
• Diagnostic Testing
• Antiviral Therapy
• Chronic Liver Disease
• Decompensated Liver Disease
• Special Patient Populations
• Liver Disease Monitoring
• Hepatology Referral

The session supports appropriate evaluation and treatment planning for patients with hepatitis B or C.

Session V – Oncology

Cancer Prevention

10:40 AM – 11:40 AM

This session reviews clinical practices and screening strategies intended to reduce cancer risk and improve early detection.

Important topics include:

• Cancer Prevention
• Preventive Medicine
• Cancer Risk Assessment
• Cancer Screening
• High-Risk Populations
• Lifestyle-Related Risk Factors
• Tobacco Cessation
• Preventive Counseling
• Evidence-Based Screening
• Appropriate Follow-Up
• Patient Education
• Risk Reduction Strategies

The session emphasizes prevention as an essential component of primary care medicine.

Approach to the Patient with Suspected Cancer

11:40 AM – 12:40 PM

This presentation reviews the clinical evaluation of patients presenting with symptoms or findings that may raise concern for malignancy.

Important considerations include:

• Suspected Malignancy
• Clinical Warning Signs
• Unexplained Symptoms
• Patient History
• Physical Examination
• Diagnostic Testing
• Laboratory Evaluation
• Imaging Considerations
• Differential Diagnosis
• Risk Stratification
• Appropriate Referral
• Diagnostic Follow-Up
• Multidisciplinary Evaluation

The educational emphasis is on developing a systematic clinical approach to recognizing and evaluating suspected cancer.

12:40 PM – Day 2 Session Adjournment

Day 3 – Sunday, October 4, 2026

Session VI – Oncology and Cancer Survivorship

Management of Cancer Survivors

7:30 AM – 8:30 AM

This session addresses medical issues affecting patients who have completed cancer treatment and require ongoing follow-up.

Cancer survivorship care may involve monitoring for disease recurrence, treatment-related complications, comorbid conditions, and long-term health risks.

Important topics include:

• Cancer Survivorship
• Cancer Recurrence Surveillance
• Follow-Up Care
• Late Treatment Effects
• Long-Term Complications
• Cardiovascular Risk
• Secondary Malignancies
• Preventive Care
• Chronic Disease Management
• Survivorship Care Planning
• Multidisciplinary Coordination
• Patient Quality of Life

The presentation emphasizes the role of primary care in coordinating long-term care for cancer survivors.

A Primary Care Review of New Oral Anticoagulants

8:30 AM – 9:30 AM

This session reviews important pharmacological and clinical considerations involving newer oral anticoagulant medications.

Important topics include:

• Direct Oral Anticoagulants
• Anticoagulant Mechanisms
• Clinical Indications
• Treatment Selection
• Therapeutic Considerations
• Bleeding Risk
• Perioperative Management
• Drug Interactions
• Anticoagulant Reversal
• Antiplatelet Medications
• Patient Monitoring
• Individualized Anticoagulation Decisions

The educational discussion emphasizes appropriate management of oral anticoagulants in primary care practice.

9:30 AM – Conference Adjournment

Major Topics Covered

• MER Primary Care Conferences 2026
• Internal Medicine for Primary Care
• Dermatology
• Gastroenterology
• Hepatology
• Oncology
• Hematology
• Lower GI Bleeding
• Occult Gastrointestinal Bleeding
• Hematochezia
• Colorectal Cancer Screening
• Colorectal Cancer Surveillance
• Colonoscopy
• Celiac Disease
• Chronic Diarrhea
• Malabsorption
• Hepatitis B
• Hepatitis C
• Viral Hepatitis
• Benign Skin Tumors
• Premalignant Skin Lesions
• Malignant Skin Tumors
• Basal Cell Carcinoma
• Squamous Cell Carcinoma
• Melanoma
• Actinic Keratosis
• Skin Biopsy
• Dermatologic Procedures
• Acne Vulgaris
• Acneiform Eruptions
• Rosacea
• Folliculitis
• Hidradenitis Suppurativa
• Skin Manifestations of Systemic Disease
• Cancer Prevention
• Early Cancer Detection
• Suspected Malignancy
• Cancer Survivorship
• Cancer Recurrence Surveillance
• Direct Oral Anticoagulants
• Anticoagulation Management
• Perioperative Anticoagulation
• Evidence-Based Primary Care
• Clinical Diagnosis
• Differential Diagnosis
• Preventive Medicine

Gastrointestinal Bleeding and Diagnostic Evaluation

Lower gastrointestinal bleeding represents an important clinical challenge across primary care, gastroenterology, and emergency medicine.

Patients may present with occult blood loss, intermittent bleeding, or major hematochezia.

The curriculum examines diagnostic strategies and treatment considerations appropriate to different clinical presentations.

Major areas include:

• Recognition of Lower GI Bleeding
• Assessment of Bleeding Severity
• Stool Blood Testing
• Diagnostic Evaluation
• Risk Stratification
• Appropriate Investigation
• Treatment Considerations
• Specialist Referral

The educational focus supports structured clinical decision-making in patients presenting with suspected gastrointestinal bleeding.

Colorectal Cancer Screening and Prevention

Colorectal cancer screening is an important component of preventive primary care.

The course reviews screening recommendations and surveillance considerations relevant to patients at average risk.

Important areas include:

• Screening Eligibility
• Colonoscopy
• Stool-Based Screening Methods
• Screening Intervals
• Follow-Up After Abnormal Findings
• Colorectal Neoplasia Prevention
• Patient Counseling
• Shared Decision-Making

The program emphasizes the importance of applying screening recommendations appropriately while considering individual patient circumstances.

Celiac Disease and Malabsorption

Celiac disease is an immune-mediated disorder associated with gluten exposure in genetically susceptible individuals.

It may present with gastrointestinal symptoms, malabsorption, nutritional abnormalities, or less typical clinical findings.

The program examines:

• Chronic Diarrhea
• Malabsorption
• Celiac Serology
• Diagnostic Testing
• Gluten-Free Diet Considerations
• Differential Diagnosis
• Nutritional Consequences
• Appropriate Referral

Particular attention is given to evaluating patients who have already adopted a gluten-free diet before undergoing diagnostic testing.

Viral Hepatitis and Liver Disease

Hepatitis B and hepatitis C remain important causes of chronic liver disease.

Primary care providers play a role in screening, vaccination, initial assessment, monitoring, and referral.

The educational discussion includes:

• HBV Screening
• HCV Screening
• Hepatitis B Vaccination
• Chronic Infection
• Antiviral Treatment
• Special Populations
• Advanced Liver Disease
• Clinical Monitoring
• Referral to Hepatology

The session supports an evidence-informed approach to viral hepatitis management.

Dermatology and Systemic Disease

Skin findings may offer important diagnostic clues to underlying medical conditions.

The curriculum examines the relationship between cutaneous manifestations and diseases affecting other organ systems.

Potential clinical areas include:

• Rheumatologic Disorders
• Endocrine Conditions
• Gastrointestinal Diseases
• Inflammatory Disorders
• Medication-Related Reactions
• Systemic Disease Recognition

The educational emphasis is on incorporating dermatologic examination into comprehensive primary care assessment.

Acne and Common Inflammatory Skin Disorders

Acne and related inflammatory dermatologic conditions are frequently encountered in outpatient practice.

The program covers diagnostic classification, clinical differentiation, and treatment selection.

Important conditions include:

• Acne Vulgaris
• Folliculitis
• Rosacea
• Hidradenitis Suppurativa
• Perioral Dermatitis
• Drug-Induced Acne
• Seborrheic Dermatitis

The session emphasizes practical treatment approaches and recognition of situations requiring specialist evaluation.

Benign and Malignant Skin Lesions

Differentiating benign from suspicious skin lesions is an important clinical responsibility.

The dermatology curriculum reviews common benign tumors and major premalignant and malignant conditions.

Important areas include:

• Nevi
• Seborrheic Keratoses
• Keloids
• Hemangiomas
• Actinic Keratosis
• Bowen’s Disease
• Basal Cell Carcinoma
• Squamous Cell Carcinoma
• Melanoma

The program emphasizes lesion assessment, appropriate biopsy selection, skin cancer prevention, and referral considerations.

Cancer Prevention and Early Diagnosis

Preventive care and early recognition of cancer are major themes of the oncology curriculum.

Primary care physicians frequently identify patients who may benefit from cancer screening, preventive counseling, or additional diagnostic evaluation.

Important areas include:

• Cancer Risk Assessment
• Screening Recommendations
• Recognition of Warning Signs
• Diagnostic Testing
• Clinical Follow-Up
• Appropriate Referral
• Patient Counseling
• Prevention Strategies

The educational content supports systematic evaluation and evidence-based preventive care.

Cancer Survivorship and Long-Term Follow-Up

Cancer survivors may experience ongoing healthcare needs after completion of treatment.

These needs may include recurrence surveillance, management of comorbidities, treatment-related complications, and preventive care.

The program examines:

• Survivorship Care
• Cancer Surveillance
• Late Treatment Effects
• Chronic Disease Management
• Risk Assessment
• Preventive Services
• Multidisciplinary Coordination
• Quality of Life

The educational focus emphasizes the continuing role of primary care in cancer survivorship.

Direct Oral Anticoagulants in Primary Care

Newer oral anticoagulants have become important treatment options in patients requiring prevention or treatment of thromboembolic disease.

Their use requires consideration of clinical indications, bleeding risk, comorbidities, interactions, and procedural management.

The course reviews:

• Oral Anticoagulant Selection
• Mechanisms of Action
• Clinical Indications
• Treatment Safety
• Perioperative Management
• Bleeding Complications
• Reversal Strategies
• Individualized Patient Care

These topics are relevant to internists and other clinicians managing patients receiving anticoagulation therapy.

Evidence-Based Clinical Decision-Making

The MER Primary Care Conferences Derm/Gastro/Onc 2026 program emphasizes the application of current medical evidence to everyday clinical practice.

Important clinical responsibilities include:

• Recognizing Important Symptoms
• Establishing Differential Diagnoses
• Selecting Appropriate Investigations
• Applying Current Screening Recommendations
• Evaluating Treatment Options
• Managing Medication-Related Risks
• Recognizing Urgent Conditions
• Coordinating Specialty Referral
• Providing Long-Term Follow-Up

The curriculum integrates clinical reasoning across dermatology, gastroenterology, oncology, and general internal medicine.

Continuing Medical Education

Medical Education Resources designated the original live educational activity for a maximum of:

• 12 AMA PRA Category 1 Credits™
• 12 ABIM MOC Points
• 12 Live AAFP Prescribed Credits
• 12 ANCC Nursing Contact Hours
• 5.5 ANCC Pharmacotherapeutic Contact Hours
• 12 AAPA Category 1 CME Credits
• 12 Interprofessional Continuing Education Credits
• 12 AOA Category 2-A Hours
• 12 ACEP Category I Credit Hours

Medical Education Resources is jointly accredited by ACCME, ACPE, and ANCC to provide continuing education for the healthcare team.

Important CME Notice

The credit amounts listed above apply to eligible participation in the original MER live educational activity under the organizer’s requirements.

Purchasing separately distributed educational files through MedicalAmboss does not provide:

• Official MER CME Credits
• ABIM MOC Points
• Official Completion Certificates
• MER Conference Registration
• Live Conference Attendance
• Publisher Streaming Access
• Official MER Accounts
• Publisher Memberships
• Publisher-Hosted Educational Extras

Why This Course Is Relevant

The MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026 program provides a multidisciplinary review of medical conditions commonly encountered in outpatient practice.

Primary care physicians frequently evaluate patients with:

• Gastrointestinal Bleeding
• Chronic Diarrhea
• Suspected Celiac Disease
• Viral Hepatitis
• Skin Manifestations of Systemic Disease
• Acne and Inflammatory Skin Conditions
• Benign and Suspicious Skin Lesions
• Cancer Screening Needs
• Symptoms Suggestive of Malignancy
• Long-Term Cancer Survivorship Needs
• Oral Anticoagulant Management Issues

The program emphasizes evidence-based diagnosis, appropriate investigations, current treatment recommendations, preventive care, and patient-specific management strategies.

Its integration of dermatology, gastroenterology, hepatology, and oncology makes it particularly relevant to internists, family medicine physicians, gastroenterologists, dermatologists, oncologists, and other healthcare professionals involved in primary care.

Official Program Reference and MedicalAmboss Purchase Scope

Official Medical Education Resources Conference:

https://www.mer.org/conference/MTIzNyxPY3RvYmVyLDIwMjY%3D/view-agenda/

Official 2026 Conference Agenda:

https://www.mer.org/wp-content/uploads/2025/10/26_1002_IM_RMP_Agenda_Web_10_15_25.pdf

These references describe the original October 2–4, 2026 conference, including its educational agenda, objectives, accreditation, and venue.

They do not establish the exact inventory of digital files included with a separately distributed MedicalAmboss product.

MedicalAmboss File Scope: This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.

Short Description

<div style=”border:2px solid #1677b8;border-radius:10px;padding:12px;background:#f7fbfe;”>

MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc 2026 provides a comprehensive, evidence-based educational review of dermatology, gastroenterology, oncology, and adult primary care medicine.

Held October 2–4, 2026, in Estes Park, Colorado, the program covers lower GI bleeding, colorectal cancer screening, celiac disease, chronic diarrhea, hepatitis B and C, acneiform disorders, skin lesions, cancer prevention, suspected malignancy, survivorship care, and oral anticoagulants.

Topics

• Friday, October 2, 2026

  • Gastroenterology: Management of Lower GI Bleeding – From Occult to Massive (The correct use and interpretation of tests for occult blood in the stool will be discussed in relation to lower GI bleeding; focus on the utility of different diagnostic and management approaches to the spectrum of patients presenting with hematochezia)

  • Gastroenterology: Colorectal Cancer Screening and Surveillance (Reviews the most recent recommendations for CRC screening in the general population at average risk for CRC)

  • Gastroenterology: Celiac Disease and Chronic Diarrhea (Millions of Americans are now on a gluten free diet. Only some of them actually have Celiac disease. We will review the workup of diarrhea and malabsorption with a focus on celiac disease; We will discuss how to diagnose celiac disease when a patient is already on a gluten free diet and an appropriate differential diagnosis)

  • Dermatology: Skin Manifestations of Systemic Disease (Skin will often reflect signs of systemic diseases, be useful for diagnosis, or suffer from a complication of disease or its treatment; Diagnosis of rheumatologic, endocrine, gastrointestinal, and psychologic conditions based on cutaneous findings)

  • Dermatology: Acne and Acneiform Eruptions (Identification of noninflammatory open or closed comedones and inflammatory lesions; Determination of treatment therapies based on acne grading scale; Bacterial folliculitis, drug-induced acne, hidradenitis suppurativa, miliaria, perioral dermatitis, pseudofolliculitis barbae, rosacea, seborrheic dermatitis; Topical and systemic therapy)

• Saturday, October 3, 2026

  • Dermatology: Benign Skin Tumors (Proper diagnosis and treatment of common benign tumors; Biopsies and histopathologic examination; Nevi, seborrheic keratosis, keloids, hemangiomas and miscellaneous tumors; When to refer)

  • Dermatology: Premalignant and Malignant Skin Tumors (Recognition of precursors of malignancies; Excisional and punch biopsies; Actinic keratosis, Bowen’s disease, squamous cell carcinoma, basal cell carcinoma, melanoma and other selected tumors; Risk reduction education)

  • Gastroenterology: Hepatitis B and C Management (HBV screening: whom to screen, whom to vaccinate; management of patients with decompensated hepatitis B related liver disease; treatment in special populations)

  • Oncology: Cancer Prevention (Cancer screening and clinical practices shown to prevent cancer will be reviewed)

  • Oncology: Approach to the Patient with Suspected Cancer (Symptoms, signs and diagnoses that raise the suspicion of cancer will be reviewed, and an approach to evaluating these patients will be presented)

• Sunday, October 4, 2026

  • Oncology: Management of Cancer Survivors (Medical issues related to cancer survivorship and approaches to surveillance for cancer recurrence will be reviewed)

  • Oncology: A Primary Care Review of New Oral Anticoagulants (Mechanisms of action, clinical indications, therapeutic indices, perioperative management and approaches to reversal of new anticoagulant and antiplatelet medications will be reviewed)